CHEMCATCHEM
FULL PAPERS
139.1 ppm; MS (EI): m/z (%): 134.0 (88), 90.9 (100); HRMS (ESI): m/z:
calcd for C17H22N (240.1747): [M+H]+; found 240.1745.
1-(4-Methylphenethyl)pyrrolidine (4i): (Table 2, entry 18) Rf =0.14
(pentane/EtOAc 75:25); yellow oil (27 mg, 0.15 mmol, 32%);
1H NMR (360 MHz, CDCl3, 294 K): d=1.75–1.89 (m, 4H), 2.33 (s, 3H),
2.53–2.63 (m, 4H), 2.64–2.74 (m, 2H), 2.78–2.88 (m, 2H), 7.07–
7.15 ppm (m, 4H); 13C{1H} NMR (90 MHz, CDCl3, 294 K): d=21.2,
23.7, 35.5, 54.4, 58.7, 128.7, 129.2, 135.6, 137.6 ppm; MS (EI) m/z
(%) 84.0 (100); HRMS (ESI): m/z: calcd for C13H20N (190.1590):
[M+H]+; found 190.1587.
1-(2-Chlorophenethyl)pyrrolidine (4a): (Table 2, entry 10) Rf =0.09
(pentane/EtOAc 75:25); yellow oil (49 mg, 0.23 mmol, 52%);
1H NMR (360 MHz, CDCl3, 294 K): d=1.76–1.87 (m, 4H), 2.58–2.78
(m, 6H), 2.96–3.04 (m, 2H), 7.10–7.22 (m, 2H), 7.26 (dd, J=7.3 Hz,
1.9 Hz, 1H), 7.33 ppm (dd, J=7.6 Hz, 1.3 Hz, 1H); 13C{1H} NMR
(90 MHz, CDCl3, 294 K): d=23.7, 33.4, 54.3, 56.3, 127.0, 127.8, 129.6,
130.9, 134.2, 138.1 ppm; MS (EI): m/z (%): 84.0 (100); HRMS (ESI):
m/z: calcd for C12H17ClN (210.1044): [M+H]+; found 210.1047.
2-(Anthracen-9-yl)-N-benzyl-N-methylethanamine (3k): (Table 3,
entry 2) Rf =0.60 (pentane/EtOAc 75:25); yellow oil (122 mg,
1
0.37 mmol, 83%); H NMR (360 MHz, CDCl3, 294 K): d=2.58 (s, 3H),
1-(3-Chlorophenethyl)pyrrolidine (4b): (Table 2, entry 11) Rf =0.09
(pentane/EtOAc 75:25); yellow oil (44 mg, 0.21 mmol, 47%);
1H NMR (360 MHz, CDCl3, 294 K): d=1.76–1.91 (m, 4H), 2.58–2.70
(m, 4H), 2.70–2.78 (m, 2H), 2.81–2.90 (m, 2H), 7.06–7.14 (m, 1H),
7.14–7.25 ppm (m, 3H). 13C{1H} NMR (90 MHz, CDCl3, 294 K): d=
23.7, 35.2, 54.3, 57.9, 126.5, 127.0, 128.9, 129.8, 134.3, 142.3 ppm;
MS (EI): m/z (%): 84.0 (100); HRMS (ESI): m/z: calcd for C12H17ClN
(210.1044): [M+H]+; found 210.1044.
2.82–2.95 (m, 2H), 3.76 (s, 2H), 3.81–3.93 (m, 2H), 7.28–7.57 (m,
9H), 8.02 (dd, J=7.4 Hz, 1.8 Hz, 2H), 8.24 (d, J=8.2 Hz, 2H),
8.36 ppm (s, 1H); 13C{1H} NMR (90 MHz, CDCl3, 294 K): d=26.3,
42.7, 57.8, 62.5 124.4, 125.0, 125.8, 126.1, 127.3, 128.5, 129.3, 129.4,
130.0, 131.8, 132.5, 139.2 ppm; MS (EI): m/z (%): 191.1 (6), 134.0
(100), 90.9 (74); HRMS (ESI): m/z: calcd for C24H24N (326.1903):
[M+H]+; found 326.1901.
1-[2-(Anthracen-9-yl)ethyl]pyrrolidine (4k): (Table 3, entry 11) Rf =
0.16 (pentane/EtOAc 75:25); yellow oil (55 mg, 0.20 mmol, 45%);
1H NMR (360 MHz, CDCl3, 294 K): d=1.84–2.00 (m, 4H), 2.71–2.93
(m, 6H), 3.82–3.95 (m, 2H), 7.42–7.58 (m, 4H), 8.02 (d, J=8.7 Hz,
2H), 8.33 (d, J=9.9 Hz, 2H), 8.35 ppm (s, 1H); 13C{1H} NMR
(90 MHz, CDCl3, 294 K): d=23.8, 28.0, 54.5, 57.0, 124.4, 125.0, 125.9,
126.2, 129.4, 130.0, 131.8, 132.3 ppm; MS (EI): m/z (%): 204.1 (26),
191.1 (27), 98.0 (38), 84.0 (100), 71.0 (25); HRMS (ESI): m/z: calcd for
C20H22N (276.1747): [M+H]+: found 276.1743.
1-(4-Chlorophenethyl)pyrrolidine (4c): (Table 2, entry 12) Rf =0.09
(pentane/EtOAc 75:25); yellow oil (44 mg, 0.21 mmol, 47%);
1H NMR (360 MHz, CDCl3, 294 K): d=1.82–1.97 (m, 4H), 2.65–2.87
(m, 6H), 2.87–2.97 (m, 2H), 7.15 (d, J=8.3 Hz, 2H), 7.26 ppm (m,
J=8.5 Hz, 2H); 13C{1H} NMR (90 MHz, CDCl3, 294 K): d=23.7, 34.5,
54.3, 57.9, 128.8, 130.2, 132.3, 138.2 ppm; MS (EI): m/z (%): 83.9
(100); HRMS (ESI): m/z: calcd for C12H17ClN (210.1044): [M+H]+;
found 210.1042. The spectra are in total accordance with the data
described in the literature.[6f]
1-(2-Methoxyphenethyl)pyrrolidine (4d): (Table 2, entry 13) Rf =
0.08 (pentane/EtOAc 75:25); yellow oil (38 mg, 0.19 mmol, 41%);
1H NMR (400 MHz, CDCl3, 294 K): d=1.76–1.88 (m, 4H), 2.55–2.76
(m, 6H), 2.81–2.91 (m, 2H), 3.82 (s, 3H), 6.80–6.92 (m, 2H), 7.13–
7.22 ppm (m, 2H); 13C{1H} NMR (100 MHz, CDCl3, 294 K): d=23.6,
30.2, 54.3, 55.4, 56.7, 110.4, 120.6, 127.5, 128.9, 130.3, 157.6 ppm;
MS (EI): m/z (%): 83.9 (100); HRMS (ESI): m/z: calcd for C13H20NO
(206.1539): [M+H]+; found 206.1543.
Anti-Markovnikov hydroamination of 2-vinylpyridine (10)
with N-methylbenzylamine or pyrrolidine
General procedure: In
[Y(CH2SiMe3)4] (12 mg, 0.025 mmol) in C6D6 (125 mL) was added to
solution of (R)-2,2’-dibenzyl-1,1’-binaphthyldiamine ligand
a glovebox, a solution of [Li(THF)4]
a
(18 mg, 0.025 mmol) in C6D6 (125 mL) at RT. The clear reaction mix-
ture turned to a deep yellow solution. The homogeneous reaction
solution was then allowed to stir for 2 min at RT, and an aliquot
(45 mL) was transferred to a vial under stirring that contained
a C6D6 solution (450 mL) of the secondary amine (0.45 mmol), 10
(0.675 mmol), and ferrocene (0.18 mmol). The reaction mixture was
then introduced into a screw-tap or a J. Young-tap NMR tube, and
1-(3-Methoxyphenethyl)pyrrolidine (4e): (Table 2, entry 14) Rf =
0.14 (pentane/EtOAc 75:25); yellow oil (48 mg, 0.23 mmol, 52%);
1H NMR (300 MHz, CDCl3, 294 K): d=1.77–1.87 (m, 4H), 2.56–2.65
(m, 4H), 2.67–2.77 (m, 2H), 2.78–2.88 (m, 2H), 3.79 (s, 3H), 6.68–
6.85 (m, 3H), 7.2 ppm (dd, J=7.8 Hz, 7.8 Hz, 1H); 13C{1H} NMR
(75 MHz, CDCl3, 294 K): d=23.6, 35.9, 54.3, 55.3, 58.3, 111.5, 114.6,
121.2, 129.5, 142.1, 159.8 ppm; MS (EI): m/z (%): 83.9 (100); HRMS
(ESI): m/z: calcd for C13H20NO (206.1539): [M+H]+; found 206.1544.
1
the progress of the reaction was monitored by H NMR spectrosco-
py using ferrocene as an internal standard. The reaction mixture
was quenched with ethanol and dried under vacuum after the ad-
dition of silica gel. The product was extracted from silica gel with
ethanol and purified on a preparative TLC plate.
1-(2-Methylphenethyl)pyrrolidine (4g): (Table 2, entry 16) Rf =0.19
(pentane/EtOAc 75:25); yellow oil (48 mg, 0.25 mmol, 57%);
1H NMR (360 MHz, CDCl3, 294 K): d=1.81–2.01 (m, 4H), 2.35 (s, 3H),
2.70–2.90 (m, 6H), 2.92–3.01 (m, 2H), 7.07–7.23 ppm (m, 4H);
13C{1H} NMR (90 MHz, CDCl3, 294 K): d=19.5, 23.7, 32.3, 54.2, 56.9,
126.3, 126.7,129.4, 130.5, 136.3, 137.6 ppm; MS (EI): m/z (%): 83.9
(100); HRMS (ESI): m/z: calcd for C13H20N (190.1590): [M+H]+; found
190.1594.
N-Benzyl-N-methyl-2-(pyridin-2-yl)ethanamine (3o): (Table 3,
entry 7) Rf =0.48 (CH2Cl2/MeOH 90:10); colorless oil (84 mg,
0.37 mmol, 82%; contaminated with 9% of the hydroaminoalkyla-
tion product; see Supporting Information); 1H NMR (300 MHz,
CDCl3, 294 K): d=2.29 (s, 3H), 2.78–2.88 (m, 2H), 2.97–3.07 (m, 2H),
3.57 (s, 2H), 7.02–7.36 (m, 7H), 7.58 (td, J=7.7 Hz, 1.9 Hz, 1H),
8.52 ppm (d, J=4.9 Hz, 1H); 13C{1H} NMR (75 MHz, CDCl3, 294 K):
d=36.4, 42.2, 57.5, 62.4, 121.2, 123.4, 127.1, 128.3, 129.1, 136.3,
139.2, 149.4, 160.8 ppm; MS (EI): m/z (%): 134.0 (92), 90.9 (100);
HRMS (ESI): m/z: calcd for C15H19N2 (227.1543): [M+H]+; found
227.1539.
1-(3-Methylphenethyl)pyrrolidine (4h): (Table 2, entry 17) Rf =0.11
(pentane/EtOAc 75:25); yellow oil (28 mg, 0.15 mmol, 32%);
1H NMR (360 MHz, CDCl3, 294 K): d=1.76–1.99 (m, 4H), 2.34 (s, 3H),
2.54–2.65 (m, 4H), 2.66–2.77 (m, 2H), 2.78–2.87 (m, 2H), 6.99–7.06
(m, 3H), 7.18 ppm (dd, J=7.3 Hz, 7.3 Hz, 1H); 13C{1H} NMR (75 MHz,
CDCl3, 294 K): d=21.5, 23.7, 35.9, 54.4, 58.6, 125.8, 126.9, 128.4,
129.6, 138.0, 140.6 ppm; MS (EI): m/z (%): 84.0 (100); HRMS (ESI):
m/z: calcd for C13H20N (190.1590): [M+H]+: found 190.1589.
2-[2-(Pyrrolidin-1-yl)ethyl]pyridine (4o): (Table 3, entry 16) Rf =
0.51 (CH2Cl2/MeOH 90:10); colorless oil (67 mg, 0.38 mmol, 84%);
1H NMR (360 MHz, CDCl3, 294 K): d=1.72–1.83 (m, 4H), 2.54–2.67
(m, 4H), 2.80–2.92 (m, 2H), 2.94–3.09 (m, 2H), 7.09 (dd, J=7.4 Hz,
ꢂ 2014 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
ChemCatChem 2014, 6, 2065 – 2073 2071